Modernizing Pharma Manufacturing: Highlights From PDA Week 2026

A Report by Mike Dingle, TSI Senior Product Specialist, Controlled Environments

If you missed PDA Week 2026 in Denver, the headline was hard to ignore: Pharmaceutical manufacturing is modernizing faster than its reputation suggests. Biofluorescent particle counters (BFPC) emerged as one of the conference's breakout topics, appearing across sessions on isolator monitoring, air quality in Grade A environments, and even AI integration. Novo Nordisk's presentation on using BioTrak BFPC as part of a standardized manufacturing network was a standout, and the technology's role in radiopharmaceutical filling is particularly striking. When your product has a half-life as short as 11 hours, waiting days for traditional microbiological results isn't a workflow inconvenience — it's a fundamental mismatch with the science.

AI's growing presence at the conference also connected back to real-time data. The point made in one session was blunt: AI can't prevent contamination events if it's working off lagging indicators. That framing recontextualizes BFPC not just as a monitoring tool but as infrastructure for intelligent manufacturing.

The Modern Microbial Methods (M3) Collaboration Group also convened in person, advancing work on User Requirement Specifications for BFPC surface testing. Access the full recap to see what these shifts mean for your contamination control strategy.